Rhumbline Advisers Lucid Diagnostics Inc. Transaction History
Rhumbline Advisers
- $113 Billion
- Q2 2025
A detailed history of Rhumbline Advisers transactions in Lucid Diagnostics Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 63,016 shares of LUCD stock, worth $78,139. This represents 0.0% of its overall portfolio holdings.
Number of Shares
63,016Holding current value
$78,139% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LUCD
# of Institutions
70Shares Held
15.3MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA4.13MShares$5.12 Million0.0% of portfolio
-
Masters Capital Management LLC Atlanta, GA2.73MShares$3.38 Million0.13% of portfolio
-
Geode Capital Management, LLC Boston, MA1.58MShares$1.96 Million0.0% of portfolio
-
Luminus Management LLC Houston, TX913KShares$1.13 Million0.86% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL738KShares$915,4630.0% of portfolio
About Lucid Diagnostics Inc.
- Ticker LUCD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 38,568,500
- Market Cap $47.8M
- Description
- Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarc...